| Literature DB >> 22245283 |
Anna Boronat1, María Sepúlveda, Sara Llufriu, Lidia Sabater, Yolanda Blanco, Iñigo Gabilondo, Nuria Solà, Pablo Villoslada, Josep Dalmau, Francesc Graus, Albert Saiz.
Abstract
Contactin-2 was recently identified as an autoantigen targeted by T-cells and autoantibodies in multiple sclerosis (MS). Here we analyzed the frequency of antibodies to contactin-2 (contactin-2-ab) by a cell-based assay in the serum from 105 MS patients and at least 5 years of follow-up (19 clinically isolated syndromes, 51 relapsing-remitting, 20 secondary-progressive, and 15 primary-progressive). Contactin-2-ab were detected in 4 (7.8%) relapsing-remitting patients. Clinical and magnetic resonance imaging characteristics were not significantly different from the rest of relapsing-remitting patients. In conclusion, contactin-2-ab are identified in a minority of MS patients but their presence is not associated with a particular clinical-radiological profile. Copyright ÂEntities:
Mesh:
Substances:
Year: 2012 PMID: 22245283 PMCID: PMC4800093 DOI: 10.1016/j.jneuroim.2011.12.023
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478